ESC 365 - Assessing CVD risk and screening for subclinical CVD in diabetes

EAPC Premium Access

Assessing CVD risk and screening for subclinical CVD in diabetes

Session: Detection of subclinical atherosclerosis

Topic: Miscellaneous

Speaker: Doctor N. Wong (Irvine, US)

Event: EuroPrevent 2017

Congress Presentation

Add to my library

About the speaker

Doctor Nathan Wong

University of California at Irvine, Irvine (United States of America)

7 presentations

0 follower

3 more presentations in this session

Early detection of CVD: which imaging method can be recommended?

Speaker: Associate Professor U. Nixdorff (Duesseldorf, DE)

Does gender influence the approach of early atherosclerosis detection?

Speaker: Doctor Y. Appelman (Amsterdam, NL)

What’s the value of biomarkers?

Speaker: Professor E. Boersma (Rotterdam, NL)

Access the full session

Detection of subclinical atherosclerosis

Speakers: Doctor N. Wong, Associate Professor U. Nixdorff, Doctor Y. Appelman, Professor E. Boersma

About the event

EuroPrevent 2017

6 April - 8 April 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources